loading
Precedente Chiudi:
$1.865
Aprire:
$1.83
Volume 24 ore:
1.52M
Relative Volume:
1.12
Capitalizzazione di mercato:
$207.57M
Reddito:
$42.51M
Utile/perdita netta:
$-116.49M
Rapporto P/E:
-1.7098
EPS:
-1.12
Flusso di cassa netto:
$-120.82M
1 W Prestazione:
+27.67%
1M Prestazione:
+30.27%
6M Prestazione:
-51.15%
1 anno Prestazione:
-72.99%
Intervallo 1D:
Value
$1.79
$2.04
Intervallo di 1 settimana:
Value
$1.47
$3.00
Portata 52W:
Value
$1.03
$12.02

Tango Therapeutics Inc Stock (TNGX) Company Profile

Name
Nome
Tango Therapeutics Inc
Name
Telefono
(857) 320-4900
Name
Indirizzo
201 BROOKLINE AVENUE, BOSTON
Name
Dipendente
155
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-06
Name
Ultimi documenti SEC
Name
TNGX's Discussions on Twitter

Confronta TNGX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
TNGX
Tango Therapeutics Inc
1.915 164.76M 42.51M -116.49M -120.82M -1.12
Biotechnology icon
ONC
Beigene Ltd Adr
241.85 24.41B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
434.94 111.55B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.31 42.47M 0 0 0 0.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
590.33 63.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
VRNA
Verona Pharma Plc Adr
74.93 5.92B 0 -153.72M -103.81M -2.00

Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-07-17 Iniziato Jefferies Buy
2024-04-04 Iniziato Cantor Fitzgerald Overweight
2024-02-12 Iniziato Piper Sandler Overweight
2023-12-08 Iniziato B. Riley Securities Buy
2022-10-20 Aggiornamento H.C. Wainwright Neutral → Buy
2021-09-20 Iniziato SVB Leerink Outperform
Mostra tutto

Tango Therapeutics Inc Borsa (TNGX) Ultime notizie

pulisher
May 22, 2025

Tango Therapeutics doses first subject in trial for MTAP-deleted tumours - Yahoo Finance

May 22, 2025
pulisher
May 21, 2025

Tango Therapeutics starts trial for brain cancer drug By Investing.com - Investing.com South Africa

May 21, 2025
pulisher
May 21, 2025

Tango Therapeutics Doses First Patient for Phase 1/2 Trial to Treat Brain Cancer - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

TNGX Initiates Phase 1/2 Trial for MTAP-Deleted Tumors | TNGX Stock News - GuruFocus

May 21, 2025
pulisher
May 21, 2025

Tango Therapeutics Announces First Patient Dosed in TNG456 - GlobeNewswire

May 21, 2025
pulisher
May 21, 2025

Tango Launches Phase 1/2 Trial for Brain Cancer Drug: New Hope for Deadly Glioblastoma Treatment - Stock Titan

May 21, 2025
pulisher
May 18, 2025

Cantor Fitzgerald Issues Positive Estimate for TNGX Earnings - Defense World

May 18, 2025
pulisher
May 16, 2025

Leerink Partnrs Analysts Boost Earnings Estimates for TNGX - Defense World

May 16, 2025
pulisher
May 15, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Just Reported Earnings, And Analysts Cut Their Target Price - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

US$10.43: That's What Analysts Think Tango Therapeutics, Inc. (NASDAQ:TNGX) Is Worth After Its Latest Results - simplywall.st

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Purchases 302,087 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 15, 2025
pulisher
May 15, 2025

Tango Therapeutics, Inc. (TNGX) Reports Q1 Loss, Lags Revenue Estimates - MSN

May 15, 2025
pulisher
May 14, 2025

Tango Therapeutics First Quarter 2025 Earnings: Misses Expectations - Yahoo Finance

May 14, 2025
pulisher
May 14, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Holdings Boosted by Wells Fargo & Company MN - Defense World

May 14, 2025
pulisher
May 13, 2025

Tango Therapeutics Extends Cash Runway Amid Clinical Progress - TipRanks

May 13, 2025
pulisher
May 12, 2025

Tango Therapeutics (TNGX) Plans $400 Million Mixed Securities Sh - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Files For Mixed Shelf Of Up To $400 Million - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Inc (TNGX) Q1 2025 Earnings: EPS of -$0.36 Mi - GuruFocus

May 12, 2025
pulisher
May 12, 2025

TNGX Reports Q1 Revenue Miss, Advances Cancer Treatments | TNGX Stock News - GuruFocus

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics, Inc. SEC 10-Q Report - TradingView

May 12, 2025
pulisher
May 12, 2025

Tango Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Highlights - GlobeNewswire

May 12, 2025
pulisher
May 12, 2025

Barclays PLC Has $307,000 Position in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 12, 2025
pulisher
May 10, 2025

Tango Therapeutics (TNGX) to Release Earnings on Monday - Defense World

May 10, 2025
pulisher
May 09, 2025

Insights into Tango Therapeutics's Upcoming Earnings - Nasdaq

May 09, 2025
pulisher
May 09, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Given Consensus Rating of “Buy” by Analysts - Defense World

May 09, 2025
pulisher
May 08, 2025

21,500 Shares in Tango Therapeutics, Inc. (NASDAQ:TNGX) Acquired by Renaissance Technologies LLC - Defense World

May 08, 2025
pulisher
May 06, 2025

JPMorgan Chase & Co. Has $97,000 Stock Holdings in Tango Therapeutics, Inc. (NASDAQ:TNGX) - Defense World

May 06, 2025
pulisher
May 05, 2025

Tango Therapeutics, Inc. (TNGX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

Medivir's Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study - Barchart.com

May 05, 2025
pulisher
May 01, 2025

There is no way Tango Therapeutics Inc (TNGX) can keep these numbers up - Sete News

May 01, 2025
pulisher
May 01, 2025

Tango Therapeutics to Report First Quarter 2025 Financial Results on Monday, May 12, 2025 - GlobeNewswire

May 01, 2025
pulisher
Apr 30, 2025

Is Tango Therapeutics Inc (TNGX) worth investing in despite its undervalued state? - uspostnews.com

Apr 30, 2025
pulisher
Apr 30, 2025

Tango Therapeutics Inc (TNGX) Stock: A Year of Highs and Lows - investchronicle.com

Apr 30, 2025
pulisher
Apr 29, 2025

Insider’s View: Deciphering Tango Therapeutics Inc (TNGX)’s Financial Health Through Ratios - DWinneX

Apr 29, 2025
pulisher
Apr 28, 2025

Layoff Tracker: Ono Cuts 83 Employees in Massachusetts - BioSpace

Apr 28, 2025
pulisher
Apr 27, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

Now Is The Time To Build A Position In Tango Therapeutics Inc (NASDAQ:TNGX) - Marketing Sentinel

Apr 26, 2025
pulisher
Apr 25, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 25, 2025
pulisher
Apr 24, 2025

Gaining Ground: Tango Therapeutics Inc (TNGX) Closes Lower at 2.35, Down -0.42 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

What is the investor’s view on Tango Therapeutics Inc (TNGX)? - uspostnews.com

Apr 24, 2025
pulisher
Apr 18, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by Franklin Resources Inc. - Defense World

Apr 18, 2025
pulisher
Apr 17, 2025

Tango Therapeutics, Inc. (NASDAQ:TNGX) Receives $12.33 Average PT from Analysts - Defense World

Apr 17, 2025
pulisher
Apr 17, 2025

Equities Analysts Offer Predictions for TNGX Q1 Earnings - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Tango Bypasses IPO Route With SPAC Merger - insights.citeline.com

Apr 16, 2025
pulisher
Apr 16, 2025

What is HC Wainwright’s Estimate for TNGX Q1 Earnings? - Defense World

Apr 16, 2025
pulisher
Apr 15, 2025

Tango Therapeutics’ (TNGX) Buy Rating Reaffirmed at HC Wainwright - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Tango Therapeutics, Inc. (TNGX) Reports Q4 Loss, Lags Revenue Estimates - MSN

Apr 14, 2025
pulisher
Apr 14, 2025

Tango Therapeutics stock holds Buy rating, $13 target from H.C. Wainwright - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Tango Therapeutics stock holds Buy rating, $13 target from H.C. Wainwright By Investing.com - Investing.com South Africa

Apr 14, 2025
pulisher
Apr 14, 2025

Little Excitement Around Tango Therapeutics, Inc.'s (NASDAQ:TNGX) Revenues As Shares Take 28% Pounding - simplywall.st

Apr 14, 2025

Tango Therapeutics Inc Azioni (TNGX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$1.16
price down icon 17.27%
$31.18
price down icon 3.94%
$578.71
price down icon 0.54%
$286.48
price down icon 0.94%
$4.10
price down icon 2.24%
$72.94
price down icon 0.11%
Capitalizzazione:     |  Volume (24 ore):